These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 32132206)

  • 21. The Contribution of Genetic Variants to the Risk of Papillary Thyroid Carcinoma in the Kazakh Population: Study of Common Single Nucleotide Polymorphisms and Their Clinicopathological Correlations.
    Mussazhanova Z; Rogounovitch TI; Saenko VA; Krykpayeva A; Espenbetova M; Azizov B; Kondo H; Matsuda K; Kalmatayeva Z; Issayeva R; Yeleubayeva Z; Madiyeva M; Mukanova A; Sandybayev M; Bolsynbekova S; Kozykenova Z; Yamashita S; Nakashima M
    Front Endocrinol (Lausanne); 2020; 11():543500. PubMed ID: 33551988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma.
    Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S
    Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
    Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
    Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study.
    Yang X; Leslie G; Gentry-Maharaj A; Ryan A; Intermaggio M; Lee A; Kalsi JK; Tyrer J; Gaba F; Manchanda R; Pharoah PDP; Gayther SA; Ramus SJ; Jacobs I; Menon U; Antoniou AC
    J Med Genet; 2018 Aug; 55(8):546-554. PubMed ID: 29730597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model.
    Hung RJ; Warkentin MT; Brhane Y; Chatterjee N; Christiani DC; Landi MT; Caporaso NE; Liu G; Johansson M; Albanes D; Marchand LL; Tardon A; Rennert G; Bojesen SE; Chen C; Field JK; Kiemeney LA; Lazarus P; Zienolddiny S; Lam S; Andrew AS; Arnold SM; Aldrich MC; Bickeböller H; Risch A; Schabath MB; McKay JD; Brennan P; Amos CI
    Cancer Res; 2021 Mar; 81(6):1607-1615. PubMed ID: 33472890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population.
    Duffek M; Skerenova M; Halasova E; Sarlinova M; Dzian A; Repiska V; Dobrovodsky A; Mistuna D; Bernadic M; Matakova T
    Bratisl Lek Listy; 2022; 123(7):475-48. PubMed ID: 35907052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel genetic susceptibility loci for calcium-containing kidney stone disease by genome-wide association study and polygenic risk score in a Taiwanese population.
    Chen WC; Chen YC; Chen YH; Liu TY; Tsai CH; Tsai FJ
    Urolithiasis; 2024 Jun; 52(1):94. PubMed ID: 38896256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common genetic variants related to genomic integrity and risk of papillary thyroid cancer.
    Neta G; Brenner AV; Sturgis EM; Pfeiffer RM; Hutchinson AA; Aschebrook-Kilfoy B; Yeager M; Xu L; Wheeler W; Abend M; Ron E; Tucker MA; Chanock SJ; Sigurdson AJ
    Carcinogenesis; 2011 Aug; 32(8):1231-7. PubMed ID: 21642358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks.
    Fritsche LG; Patil S; Beesley LJ; VandeHaar P; Salvatore M; Ma Y; Peng RB; Taliun D; Zhou X; Mukherjee B
    Am J Hum Genet; 2020 Nov; 107(5):815-836. PubMed ID: 32991828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
    He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
    Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GWAS-based polygenic risk scoring for predicting cerebral artery dissection in the Chinese population.
    Zhang S; Zhu D; Wu Z; Yang S; Liu Y; Kang X; Chen X; Zhu Z; Dong Q; Suo C; Han X
    BMC Neurol; 2024 Jul; 24(1):258. PubMed ID: 39054468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the ATM gene polymorphisms with papillary thyroid cancer.
    Gu Y; Yu Y; Ai L; Shi J; Liu X; Sun H; Liu Y
    Endocrine; 2014 Apr; 45(3):454-61. PubMed ID: 23925578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations.
    Dai J; Lv J; Zhu M; Wang Y; Qin N; Ma H; He YQ; Zhang R; Tan W; Fan J; Wang T; Zheng H; Sun Q; Wang L; Huang M; Ge Z; Yu C; Guo Y; Wang TM; Wang J; Xu L; Wu W; Chen L; Bian Z; Walters R; Millwood IY; Li XZ; Wang X; Hung RJ; Christiani DC; Chen H; Wang M; Wang C; Jiang Y; Chen K; Chen Z; Jin G; Wu T; Lin D; Hu Z; Amos CI; Wu C; Wei Q; Jia WH; Li L; Shen H
    Lancet Respir Med; 2019 Oct; 7(10):881-891. PubMed ID: 31326317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variants in microRNA genes in familial papillary thyroid carcinoma.
    Tomsic J; Fultz R; Liyanarachchi S; Genutis LK; Wang Y; Li W; Volinia S; Jazdzewski K; He H; Wakely PE; Senter L; de la Chapelle A
    Oncotarget; 2017 Jan; 8(4):6475-6482. PubMed ID: 28031538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of breast cancer risk genes and establishment of a prediction model based on estrogen metabolism regulation.
    Zhao F; Hao Z; Zhong Y; Xu Y; Guo M; Zhang B; Yin X; Li Y; Zhou X
    BMC Cancer; 2021 Feb; 21(1):194. PubMed ID: 33632172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in matricellular SPP1 and SPARC contribute to susceptibility to papillary thyroid cancer.
    Su X; Xu BH; Zhou DL; Ye ZL; He HC; Yang XH; Zhang X; Liu Q; Ma JJ; Shao Q; Yang AK; He CY
    Genomics; 2020 Nov; 112(6):4959-4967. PubMed ID: 32919020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical behavior and genetics of nonsyndromic, familial nonmedullary thyroid cancer.
    Bauer AJ
    Front Horm Res; 2013; 41():141-8. PubMed ID: 23652675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma.
    Qian X; Tang J; Li L; Chen Z; Chen L; Chu Y
    Bioengineered; 2021 Dec; 12(1):2341-2351. PubMed ID: 34077308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep neural network improves the estimation of polygenic risk scores for breast cancer.
    Badré A; Zhang L; Muchero W; Reynolds JC; Pan C
    J Hum Genet; 2021 Apr; 66(4):359-369. PubMed ID: 33009504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.
    Wójcicka A; Czetwertyńska M; Świerniak M; Długosińska J; Maciąg M; Czajka A; Dymecka K; Kubiak A; Kot A; Płoski R; de la Chapelle A; Jażdżewski K
    Genes Chromosomes Cancer; 2014 Jun; 53(6):516-23. PubMed ID: 24599715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.